Home › Compare › CERGF vs ABBV
CERGF yields 44.84% · ABBV yields 3.06%● Live data
📍 CERGF pulled ahead of the other in Year 1
Combined, CERGF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CERGF + ABBV for your $10,000?
Ceres Global Ag Corp. procures and provides agricultural commodities and value-added products, industrial products, fertilizers, energy products, and supply chain logistics and storage services worldwide. The company operates through Grain; Supply Chain Services; and Seed and Processing segments. It engages in the procurement, storage, handling, trading, and merchandising of commodity, and specialty grains and oilseeds, such as oats, barley, rye, hard red spring wheat, durum wheat, canola, and pulses through 10 grain storage and handling facilities in Minnesota, Manitoba, Saskatchewan, and Ontario. The company also provides logistics, storage, and transloading services for non-agricultural commodities and industrial products. In addition, it is involved in the soybean crush, specialty crops blending, birdfeed production, and seed distribution businesses. Ceres Global Ag Corp. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Full CERGF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.